Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Onc.AI Raises $25 Million Series A Financing Co-Led by MassMutual and Action Potential Venture Capital
Onc.AI, a medical technology company developing a novel digital clinical management solution focused on immuno-oncology, […]
Orbit Discovery and SanegeneBio Collaborate to Identify Targeting Peptides for RNAi Drugs
Orbit Discovery, a leader in the discovery of therapeutic peptide hits, has announced it has […]
Turbine’s AI-powered Cancer Cell Simulations Will Be Used to Identify Novel Disease Positioning Strategies in Cancer Research UK’s Latest Biotech Partnership
Cancer Research Horizons, the innovation engine at the core of the world’s largest private funder […]
IntoCell Enters into Development and License Option Agreement with ADC Therapeutics
IntoCell has announced the signing of a Material Transfer Agreement (MTA) with option to license […]
B dot Medical to Install Its First Practical Ultra-compact Proton Therapy System at Hospital in Tokyo
B dot Medical has signed a memorandum of understanding with Edogawa Hospital in Japan for […]
Tempero Bio has Received FDA Clearance to Advance Clinical Development of TMP-301 for Treatment of Alcohol and Substance Use Disorders
Sosei Group Corporation, the world leader in G protein-coupled receptor (GPCR) focused structure-based drug design […]
BICO Group Appoints Marius Balger as New COO
BICO Group is pleased to announce the appointment of Marius Balger as Chief Operating Officer […]
Amneal Announces Strategic European Partnership with Orion Corporation
Amneal Pharmaceuticals, has announced it has signed a long-term license agreement with Orion Corporation to […]
Zhongchao Announces Drug Distributorship in China of Indian Generic Drugs of Natco Pharma
Zhongchao, a platform-based internet technology company offering services to patients with oncology and other major […]
Medisafe Expands Business Solutions with New Software as a Medical Device (SaMD)
Medisafe, a leading digital therapeutics company specializing in medication engagement, is pleased to announce its […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more